Owkin and CRO Aviano Sign Master Partnership Agreement to Foster Collaborative Oncology Research
Owkin official newsroom · Indexed industry source record · Source published: Fri Aug 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:09:15 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
PARIS & PORDENONE, Italy — Owkin, the agentic AI company pioneering the first autonomous AI scientist to revolutionize drug discovery and development, and the Centro di Riferimento Oncologico di Aviano (CRO), a leading Italian National Cancer Institute (IRCCS) dedicated to research and care, today announced the signature of a Master Partnership Agreement aimed at facilitating connections and colla
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.